Cargando…
1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection
BACKGROUND: Limited literature on the impact of COVID-19 infection in persons living with HIV infection (PLWHIV) has shown conflicting results, especially on the degree of disease severity and morbidity/mortality risk impact. The advent of vaccinations against COVID-19 infection helped combat this h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751770/ http://dx.doi.org/10.1093/ofid/ofac492.931 |
_version_ | 1784850553686196224 |
---|---|
author | Bangash, Salman Betancourth, Adriana Khan, Ayesha Hsiao, Chiu-Bin Oehler, Cassandra Abalos, Charmaine Clarisse D |
author_facet | Bangash, Salman Betancourth, Adriana Khan, Ayesha Hsiao, Chiu-Bin Oehler, Cassandra Abalos, Charmaine Clarisse D |
author_sort | Bangash, Salman |
collection | PubMed |
description | BACKGROUND: Limited literature on the impact of COVID-19 infection in persons living with HIV infection (PLWHIV) has shown conflicting results, especially on the degree of disease severity and morbidity/mortality risk impact. The advent of vaccinations against COVID-19 infection helped combat this horrific pandemic. However, their efficacy in immunocompromised hosts is understudied. The measurement of anti-spike antibody levels makes them an ideal surrogate to study the efficacy of the immune response conferred after vaccination. METHODS: A quality improvement project was conducted between 03/2020 and 03/2022 at Positive Health Clinic (PHC), a Pittsburgh urban Ryan White-funded HIV clinic, where approximately 930 PLWHIV receive care. PHC patients who tested positive for COVID-19 were followed up for their clinical presentations and outcomes. Goals were to observe longitudinal clinical impact with or without vaccinations; the COVID-19 vaccination acceptance and its serum anti-spike antibody response (AS-Ab); and COVID-19 variants impact on protection by vaccination. RESULTS: By 02/21, a 70% vaccination rate was achieved for PHC PLWHIV. 136 serum AS-Ab tests were collected at least 28 days after completing the primary vaccination series. Five non-responders were noted (2 renal transplant recipients, 2 with advanced AIDS with uncontrolled HIV, and 1 with liver cirrhosis). Low AS-Ab titers were observed in patients with CD4 < 200 or HIV VL > 200. A total of 109 COVID-19 infections in 105 patients were seen. From 03/20 – 11/21, there were 53 infections noted (45 unvaccinated: 5 with severe disease; 8 vaccinated: 0 severe disease). 58 infections (8 unvaccinated, 2 severe, 50 vaccinated (including four 2nd infections: 0 severe) were observed during 11/221 – 03/22. No mortality was noted. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This report did not show mortality directly associated with COVID-19 infection in PLWHIV. Moreover, COVID-19 vaccination is known to reduce the risk and severity of COVID-19 infection in the general population, which was consistent across our study. Interestingly, there were very few COVID-19 infections diagnosed in PLWHIV who had low CD4 count and uncontrolled HIV (CD4 < 200 & HIV VL > 500 copies) even after the surge of the Omicron variant. DISCLOSURES: All Authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-9751770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97517702022-12-16 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection Bangash, Salman Betancourth, Adriana Khan, Ayesha Hsiao, Chiu-Bin Oehler, Cassandra Abalos, Charmaine Clarisse D Open Forum Infect Dis Abstracts BACKGROUND: Limited literature on the impact of COVID-19 infection in persons living with HIV infection (PLWHIV) has shown conflicting results, especially on the degree of disease severity and morbidity/mortality risk impact. The advent of vaccinations against COVID-19 infection helped combat this horrific pandemic. However, their efficacy in immunocompromised hosts is understudied. The measurement of anti-spike antibody levels makes them an ideal surrogate to study the efficacy of the immune response conferred after vaccination. METHODS: A quality improvement project was conducted between 03/2020 and 03/2022 at Positive Health Clinic (PHC), a Pittsburgh urban Ryan White-funded HIV clinic, where approximately 930 PLWHIV receive care. PHC patients who tested positive for COVID-19 were followed up for their clinical presentations and outcomes. Goals were to observe longitudinal clinical impact with or without vaccinations; the COVID-19 vaccination acceptance and its serum anti-spike antibody response (AS-Ab); and COVID-19 variants impact on protection by vaccination. RESULTS: By 02/21, a 70% vaccination rate was achieved for PHC PLWHIV. 136 serum AS-Ab tests were collected at least 28 days after completing the primary vaccination series. Five non-responders were noted (2 renal transplant recipients, 2 with advanced AIDS with uncontrolled HIV, and 1 with liver cirrhosis). Low AS-Ab titers were observed in patients with CD4 < 200 or HIV VL > 200. A total of 109 COVID-19 infections in 105 patients were seen. From 03/20 – 11/21, there were 53 infections noted (45 unvaccinated: 5 with severe disease; 8 vaccinated: 0 severe disease). 58 infections (8 unvaccinated, 2 severe, 50 vaccinated (including four 2nd infections: 0 severe) were observed during 11/221 – 03/22. No mortality was noted. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: This report did not show mortality directly associated with COVID-19 infection in PLWHIV. Moreover, COVID-19 vaccination is known to reduce the risk and severity of COVID-19 infection in the general population, which was consistent across our study. Interestingly, there were very few COVID-19 infections diagnosed in PLWHIV who had low CD4 count and uncontrolled HIV (CD4 < 200 & HIV VL > 500 copies) even after the surge of the Omicron variant. DISCLOSURES: All Authors: No reported disclosures. Oxford University Press 2022-12-15 /pmc/articles/PMC9751770/ http://dx.doi.org/10.1093/ofid/ofac492.931 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstracts Bangash, Salman Betancourth, Adriana Khan, Ayesha Hsiao, Chiu-Bin Oehler, Cassandra Abalos, Charmaine Clarisse D 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title | 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title_full | 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title_fullStr | 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title_full_unstemmed | 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title_short | 1091. HIV Does Not Increase Risk of Disease Severity in Patients with COVID-19 Infection |
title_sort | 1091. hiv does not increase risk of disease severity in patients with covid-19 infection |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751770/ http://dx.doi.org/10.1093/ofid/ofac492.931 |
work_keys_str_mv | AT bangashsalman 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection AT betancourthadriana 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection AT khanayesha 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection AT hsiaochiubin 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection AT oehlercassandra 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection AT abaloscharmaineclarissed 1091hivdoesnotincreaseriskofdiseaseseverityinpatientswithcovid19infection |